Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 31 Prostatic Neoplasms 17 Breast Neoplasms 8 Sarcoma 6 Vaginal Neoplasms 4 Neoplasms 4 Endometrial Neoplasms 4 Vulvar Neoplasms 3 Uterine Neoplasms 3 Lung Neoplasms 3 Carcinoma, Ductal, Breast 3 Radiation Injuries 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Desmoplastic Small Round Cell Tumor 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Anemia 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Recurrent Head and Neck Carcinoma 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1

Interventions

Fluorouracil 7 Radiotherapy 6 Cisplatin 6 Mitomycin 3 Cetuximab 2 toripalimab 1 atezolizumab 1 Vaccines 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Neoadjuvant Therapy 1 Mitomycins 1 Docetaxel 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anal Canal Carcinoma × Brachytherapy × Clear all

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡